Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Century Therapeutics, Inc. (IPSC) had Free Cash Flow per Share of $-0.23 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-34.55M |
|
-- |
|
-- |
|
$36.53M |
|
$-36.53M |
|
$1.98M |
|
$-34.55M |
|
$-34.55M |
|
$-34.55M |
|
$-34.55M |
|
$-34.55M |
|
$-34.55M |
|
$-36.53M |
|
$-34.06M |
|
205.78M |
|
205.78M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$124.77M |
|
$34.48M |
|
$162.24M |
|
$287.01M |
|
$15.07M |
|
-- |
|
$39.59M |
|
$54.66M |
|
$232.34M |
|
$198.15M |
|
$232.34M |
|
180.55M |
|
| Cash Flow Statement Financials | |
$-45.10M |
|
$-94.85M |
|
$126.93M |
|
$65.01M |
|
$52.00M |
|
$-13.01M |
|
$3.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.87% |
|
-17.44% |
|
-12.04% |
|
-14.87% |
|
$1.29 |
|
|
Free Cash Flow per Share |
$-0.23 |
$-0.22 |
|